Cargando…
Dihydromyricetin Induces Apoptosis and Reverses Drug Resistance in Ovarian Cancer Cells by p53-mediated Downregulation of Survivin
Ovarian cancer is one of the leading causes of death in gynecological malignancies, and the resistance to chemotherapeutic agents remains a major challenge to successful ovarian cancer chemotherapy. Dihydromyricetin (DHM), a natural flavonoid derived from Ampeopsis Grossdentata, has been widely appl...
Autores principales: | Xu, Yingqi, Wang, Shengpeng, Chan, Hon Fai, Lu, Huaiwu, Lin, Zhongqiu, He, Chengwei, Chen, Meiwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402300/ https://www.ncbi.nlm.nih.gov/pubmed/28436480 http://dx.doi.org/10.1038/srep46060 |
Ejemplares similares
-
Decitabine and SAHA-Induced Apoptosis Is Accompanied by Survivin Downregulation and Potentiated by ATRA in p53-Deficient Cells
por: Brodská, Barbora, et al.
Publicado: (2014) -
Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
por: Tabata, Mitsuki, et al.
Publicado: (2020) -
Noscapine Induced Apoptosis via Downregulation of Survivin in Human Neuroblastoma Cells Having Wild Type or Null p53
por: Li, Shiwang, et al.
Publicado: (2012) -
Reversal Effect of Dihydromyricetin on Multiple Drug Resistance in SGC7901/5-FU Cells
por: Wu, Mingcai, et al.
Publicado: (2020) -
Golgi reassembly and stacking protein 65 downregulation is required for the anti-cancer effect of dihydromyricetin on human ovarian cancer cells
por: Wang, Fengjie, et al.
Publicado: (2019)